首页 >
法规速递
-
Page: Parallel scientific advice and special development aspects or product types-2025/11/17
2025-11-18查看详情 > -
Document: Guideline on stability testing for applications for variations to a marketing authorisation - Revision 3-2025/12/12
2025-12-15查看详情 > -
国家药监局关于暂停进口、销售和使用Sun Pharmaceutical Industries Limited重酒石酸卡巴拉汀胶囊的公告（2026年第12号） -2026/1/26
2026-01-27查看详情 > -
Document: Minutes of the CAT meeting 21-23 January 2026-2026/3/4
2026-03-05查看详情 > -
Document: Paediatric addendum to CHMP guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension-2026/3/31
2026-04-01查看详情 > -
Stimulant Use Disorders: Developing Drugs for Treatment-2026/5/13
2026-05-15查看详情 > -
Regulatory and procedural guideline: Procedural advice for orphan medicinal product designation: Guidance for sponsors-2022/11/7
2022-11-30查看详情 > -
Scientific guideline: Draft ICH E6 (R3) Guideline on good clinical practice (GCP) - Step 2b-2023/5/26
2023-05-30查看详情 > -
关于公开征求《药品变更受理审查指南（试行）（征求意见稿）》意见的通知-2023/11/28
2023-12-04查看详情 > -
Document: Policy 29: Representing the Agency at external events or in professional bodies-2025/1/20
2025-01-21查看详情 >
